Authors
Loading...
This review highlights galectin-3's role as a biomarker for cardiovascular and renal dysfunction in diabetes, suggesting improved patient management.
Buliga-Finiș et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: